3-(Cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 16, 2007
Grant Date -
Jan 19, 2006
app pub date -
Oct 16, 2003
filing date -
Oct 16, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides compounds of the formula: ##STR00001## wherein (a) is a single or double bond; W is CH, CH.sub.2, CHCH.sub.3, CCH.sub.3, C(CH.sub.3).sub.2, C(CH.sub.2).sub.2 or C(CH.sub.2).sub.3, provided that when (a) is a double bond, then W is CH or CCH.sub.3, and when (a) is a single bond, then W is CH.sub.2, CHCH.sub.3, C(CH.sub.3).sub.2, C(CH.sub.2).sub.2 or C(CH.sub.2).sub.3; X is CH or N; and Y is H or F, and salts, hydrates, tautomers, pure enantiomers, and enantiomeric mixtures; and a method of treating schizophrenia comprising administering same.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully